The deadline for fiscal year 2021 US OTC monograph program facility fees has passed and the FY2022 fees are due in seven months at amounts not yet set.
What is set, though, is that marketers of OTC drugs available under a Food and Drug Administration monograph which haven’t...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?